Teleflex is divided into two listed companies on the stock market
Teleflex has also announced its intention to divide into two separate entities: a new independent company made up of its urology, active care and OEM companies and a second company made up of its vascular access, its interventional and surgical companies. The newly acquired biotronik assets will be a key element of this last company.
“This transaction is designed to optimize the positioning of the two companies in order to better meet the needs of patients and customers and maximize the value of shareholders,” said Kelly Separate declaration.
Once the separation is finalized – the process can take more than a complete calendar year – Kelly will remain in its position and supervise vascular access, interventional and surgical companies. New leaders will soon be identified for urology, active care and OEM companies.
Biotronik moves his goal
For Biotronik, his decision represents a key element of his new strategy to “strengthen his leadership in implantable active devices and digital health care”.
“We are incredibly proud of transformative contributions that our vascular intervention division has provided interventional therapies and patient care worldwide”, “,” Dr Alexander UHLCEO of Biotronik Group, said in a business declaration. “While health care continues to evolve quickly, we are firmly focusing on the progression of AI -focused technologies that meet the needs of patients and clinicians in the years to come. This strategic change allows us to amplify our investments in emerging technologies through the management of heart rate, patient monitoring, heart failure and neuromodulation therapies.